---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-135942"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T23:15:51.840024+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Teva shareholders elect board, approve executive compensation and auditor at annual meeting

## Summary
- Chen Lichtenstein elected to board until 2027; Amir Elstein, Roberto Mignone, Perry Nisen, Tal Zaks elected until 2028.
- Non-binding advisory vote on executive compensation approved with 688.8M for vs 99.2M against.
- Amended compensation policy for executives and directors approved with 710.2M for.
- Reappointment of Kesselman & Kesselman (PwC) as auditor approved with 820.2M for.
- All proposals passed with substantial majorities; no material dissent reported.

## SEC filing metadata
- accession: 0001193125-25-135942
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312525135942/0001193125-25-135942-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312525135942/d90930d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-135942
- JSON: https://secwatch.observer/filing/0001193125-25-135942.json
- Plain text: https://secwatch.observer/filing/0001193125-25-135942.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.